Study of Lenvatinib w/ Pembro in Black Participants w/Mismatch Repair-Prof Recurrent Endometrial Cancer
Phase 2 Terminated
4 enrolled 8 charts
A Study to Investigate LYL797 in Adults With Solid Tumors
Phase 1 Terminated
57 enrolled
START
Terminated
10 enrolled
NIRAPK
Phase 4 Terminated
12 enrolled
COMPASS
Phase 4 Terminated
89 enrolled 20 charts
Newton
Phase 2 Terminated
83 enrolled
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)
Phase 1/2 Terminated
79 enrolled
Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies
Phase 1/2 Terminated
79 enrolled 18 charts
DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers
Phase 2 Terminated
41 enrolled 13 charts
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
UP-NEXT
Phase 3 Terminated
20 enrolled
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
Phase 1/2 Terminated
223 enrolled 50 charts
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
Phase NA Terminated
6 enrolled 7 charts
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
Phase 1/2 Terminated
7 enrolled 9 charts
An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Phase 2 Terminated
25 enrolled 14 charts
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
Terminated
5 enrolled
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Phase 2 Terminated
67 enrolled 37 charts
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Phase 2 Terminated
12 enrolled 12 charts
ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors
Phase 1/2 Terminated
46 enrolled 17 charts
NRR
Phase 2 Terminated
3 enrolled 9 charts
Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma
Phase 2 Terminated
22 enrolled
Doxil and Gemcitabine in Recurrent Ovarian Cancer
Phase 2 Terminated
24 enrolled
Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
Terminated
252 enrolled
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin
Phase 2 Terminated
14 enrolled 10 charts
ITOV04
Phase 1 Terminated
3 enrolled
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Terminated
256 enrolled
ChemoFx® PRO - A Post-Market Data Collection Study
Terminated
2,756 enrolled
A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
Terminated
167 enrolled
Study of XL999 in Patients With Previously Treated Ovarian Cancer
Phase 2 Terminated
24 enrolled
Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
Phase 2 Terminated
45 enrolled